Key to icons

Video
Company news
Product news
Downloads
Application news
Technical Articles

Nanogen

All articles from Nanogen

Nanogen wins CDC contract for avian flu diagnostic

Goal is to develop POC immunoassay that simultaneously detects influenza type A, type B, seasonal flu (H1N1 and H3N2) and avian flu (H5N1) in a simple to use assay format

News from Laboratorytalk, 6 December 2006

Nanogen releases new real-time PCR reagents

MGB Alert real-time PCR reagents assist laboratories in developing tests that can detect sequences associated with varicella-zoster virus (VZV, also called Human Herpesvirus 3) and Bordetella bacteria

News from Laboratorytalk, 28 July 2006

Pharmacogenetics product achieves CE mark for IVD

Jurilab, a privately-held Finnish biotechnology company, and Nanogen announce that the European CE Mark for IVD (in vitro diagnostic) use has been achieved for the Drugmet pharmacogenetic test

News from Laboratorytalk, 4 May 2006

Detection of Epstein-Barr virus (EBV)

EBV, Epstein-Barr virus, is the causative agent of infectious mononucleosis and also underlies several other lymphoproliferative disorders such as Burkitt's lymphoma

News from Laboratorytalk, 27 April 2006

Nanogen to buy diagnostics firm Amplimedical

Based in Italy, the Amplimedical diagnostics division has been active in the European and other markets since the early 1990s with its molecular diagnostic reagents

News from Laboratorytalk, 24 April 2006

Expanding reach into molecular diagnostics

Nanogen, developer of advanced diagnostic products, announced that Fisher Scientific International has agreed to purchase approximately 5.7 million shares of Nanogen common stock at $2.65 per share

News from Laboratorytalk, 22 March 2006

Acquisition of point-of-care cardiac diagnostics

Cardiac Status line includes four FDA-cleared tests that can be used at the point-of-care to determine elevations of cardiac markers, diagnose acute coronary syndrome (ACS) as indicated by chest pain

News from Laboratorytalk, 9 February 2006

Detection of respiratory viral pathogens

Nanogen has expanded its molecular reagent product portfolio to include two new products to detect sequences for respiratory viral pathogens

News from Laboratorytalk, 14 December 2005

Molecular biology on second-generation chip system

Open and robust platform allows laboratories to use one system for multiple molecular applications, including the detection of SNPs and multi-gene targets for pharmacogenetics

News from Laboratorytalk, 25 October 2005

Fluorescent detection of nucleic acid targets

Patent relates to latent fluorophore-minor groove binder oligonucleotide conjugates which fluoresce upon hybridisation to a target

News from Laboratorytalk, 13 October 2005

Share sale to bolster balance sheet

"This financing will bolster our balance sheet as we prepare to launch products for the clinical, research and point-of-care markets," said Howard Birndorf, chairman and CEO

News from Laboratorytalk, 30 September 2005

$2.5M to develop diagnostics for sepsis, pneumonia

Grant will enable Nanogen to develop improved molecular biological methods, miniaturise those methods, and demonstrate this new molecular diagnostic approach in a hospital laboratory setting

News from Laboratorytalk, 15 August 2005

Metrohm offers TOC-measurement tool

Metrohm is offering the LAR QuickTOC for the measurement of TOC.
IEF solution features peptide-based PL marker kit

Beckman Coulter has introduced advanced isoelectric-focusing (IEF) technology, featuring a peptide-based PL marker kit for the charge-heterogeneity analysis of biotherapeutics.

Browse by category

Laboratorytalk